EKSO Ekso Bionics Holdings, Inc. - 8-K

Item
2.05 Costs Associated with Exit or Disposal Activities.

On
May 29, 2026, the Board of Directors (the “Board”) of ChronoScale Corporation, a Nevada corporation (the “Company”)
committed to a plan to divest its wholly owned subsidiary, Ekso Bionics, Inc., a Delaware corporation (“Ekso”) which had
not previously been announced as being held for sale, and to focus the Company’s operations solely on its cloud business. The Company
expects to complete the divesture of the Ekso business during the first fiscal quarter. In connection with this action, the Company expects
to incur material charges, including severance costs, lease termination payments, transaction-related expenses, and other exit costs.

The
Company is not yet able to make a good-faith estimate of the total amount or range of amounts expected to be incurred in connection with
this action, or the amounts or range of amounts for each major type of charge. The Company undertakes to amend this Current Report on
Form 8-K to include this information within four business days after it makes a determination of such estimates or range of estimates,
as required by Item 2.05(d) of Form 8-K.

Forward-Looking
Statements

This
Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the expected costs, timing, and financial impact of the planned divestiture of the Ekso business.
Words such as “anticipates,” “expects,” “intends,” “plans,” “projects,” “believes,”
“seeks,” “estimates,” “can,” “may,” “will,” “would” and similar
expressions identify such forward-looking statements. These statements are not guarantees of results and should not be considered an
indication of future activity or future performance. Actual results may differ materially from those expressed or implied by such
forward-looking statements due to a variety of factors, including, but not limited to, changes in estimates of costs associated with
the divestiture, including severance, lease termination expenses, and other exit-related charges; the timing and completion of the divestiture;
the Company’s ability to successfully execute the wind-down or sale of the Ekso business; and general economic, market, and business
conditions. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the
date of this report, except as required by law.

2